News
Overview of Plasma Therapy MarketThe global Plasma Therapy Market is valued at USD 354.33 Billion in 2024 and is projected to reach a value of USD 1575 Billion by 2035 at a CAGR (Compound Annual ...
Stretching nearly 2700km across southern Australia, the drive from Adelaide to Perth is one of the world’s classic long-haul ...
What to know about COVID symptoms, testing and incubation as the new "razor blade throat" Nimbus variant has caused a summer 2025 spike.
Following the FDA ODAC's vote against belantamab mafodotin-based combinations in relapsed/refractory multiple myeloma, George Mulligan, PhD, provides insight into the agent's potential path foward.
12h
Barchart on MSNThis ‘Strong Buy’ Stock Could Be the Next Big Biotech BreakoutClinical-stage biotech stocks carry significant risks, but also offer explosive upside potential. These companies are built ...
ORLANDO, FLORIDA / ACCESS Newswire / July 18, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and BullFrog AI, Inc. (Nasdaq:BFRG) on the RedChip Small St ...
Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation ( ...
14h
The Healthy @Reader's Digest on MSN13 Supplement or Medication Combos You Should Never MixYou might turn to the mineral for help in staving off or shortening the duration of common colds, but you should know that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results